This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
YOUNOSSI; KOENIG; ABDELATIF; FAZEL; HENRY; WYMER. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016, 64, 73–84, doi:10.1002/hep.28431.Search in Google Scholar
CHRYSAVGIS; ZTRIVA; PROTOPAPAS; TZIOMALOS; CHOLONGITAS. Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management. World J Gastroenterol 2020, 26, 6514–6528, doi:10.3748/wjg.v26.i42.6514.Search in Google Scholar
NEWSOME; SCHATTENBERG; SERFATY; AGHEMO; AUGUSTIN; TSOCHATZIS; et al. The economic cost and health burden of non-alcoholic steatohepatitis in the EU5 countries. Digestive and Liver Disease 2020, 52, e33–e34, doi:10.1016/j.dld.2019.12.121.Search in Google Scholar
YOUNOSSI; TAMPI; RACILA; QIU; BURNS; YOUNOSSI; et al. Economic and Clinical Burden of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes in the U.S. Diabetes Care 2020, 43, 283–289, doi: 10.2337/dc19-1113.Open DOISearch in Google Scholar
GASTALDELLI; CUSI. From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options. JHEP Rep 2019, 1, 312–328, doi: 10.1016/j.jhepr.2019.07.002.Open DOISearch in Google Scholar
BRUNT; KLEINER; CARPENTER; RINELLA; HARRISON; LOOMBA; et al. NAFLD: Reporting Histologic Findings in Clinical Practice. Hepatology 2021, 73, 2028–2038, doi: 10.1002/hep.31599.Open DOISearch in Google Scholar
CUSI. Nonalcoholic fatty liver disease in type 2 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes 2009, 16, 141–149, doi: 10.1097/MED.0b013e3283293015.Open DOISearch in Google Scholar
HILLENBRAND; KIEBLER; SCHWAB; SCHEJA; XU; HENNE-BRUNS; et al. Prevalence of non-alcoholic fatty liver disease in four different weight related patient groups: association with small bowel length and risk factors. BMC Res Notes 2015, 8, 290, doi: 10.1186/s13104-015-1224-7.Open DOISearch in Google Scholar
MACHADO; MARQUES-VIDAL; CORTEZ-PINTO. Hepatic histology in obese patients undergoing bariatric surgery. J Hepatol 2006, 45, 600–606, doi: 10.1016/j.jhep.2006.06.013.Open DOISearch in Google Scholar
WONG; CHAN; CHITTURI; CHAWLA; DAN; DUSEJA; et al. Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017–Part 1: Definition, risk factors and assessment. J Gastroenterol Hepatol 2018, 33, 70–85, doi: 10.1111/jgh.13857.Open DOISearch in Google Scholar
CHALASANI; YOUNOSSI; LAVINE; CHARLTON; CUSI; RINELLA; et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2018, 67, 328–357, doi: 10.1002/hep.29367.Open DOISearch in Google Scholar
LOOMIS; KABADI; PREISS; HYDE; BONATO; ST LOUIS; et al. Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies. J Clin Endocrinol Metab 2016, 101, 945–952, doi: 10.1210/jc.2015-3444.Open DOISearch in Google Scholar
YOUNOSSI; GOLABI; DE AVILA; PAIK; SRISHORD; FUKUI; et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis. J Hepatol 2019, 71, 793–801, doi: 10.1016/j.jhep.2019.06.021.Open DOISearch in Google Scholar
ANGULO; KEACH; BATTS; LINDOR. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999, 30, 1356–1362, doi: 10.1002/hep.510300604.Open DOISearch in Google Scholar
DIXON; BHATHAL; O'BRIEN. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001, 121, 91–100, doi: 10.1053/gast.2001.25540.Open DOISearch in Google Scholar
EGUCHI; HYOGO; ONO; MIZUTA; ONO; FUJIMOTO; et al. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study. J Gastroenterol 2012, 47, 586–595, doi: 10.1007/s00535-012-0533-z.Open DOISearch in Google Scholar
HAGSTROM; NASR; EKSTEDT; STAL; HULTCRANTZ; KECHAGIAS. Accuracy of Noninvasive Scoring Systems in Assessing Risk of Death and Liver-Related Endpoints in Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol 2019, 17, 1148–1156 e1144, doi: 10.1016/j.cgh.2018.11.030.Open DOISearch in Google Scholar
GHAEMI; HOSSEINI; OSATI; NAGHIZADEH; DEHGHAN; EHRAMPOUSH; et al. Waist circumference is a mediator of dietary pattern in Non-alcoholic fatty liver disease. Sci Rep 2018, 8, 4788, doi: 10.1038/s41598-018-23192-x.Open DOISearch in Google Scholar
HUANG; GREENSON; CHAO; ANDERSON; PETERMAN; JACOBSON; et al. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study. Am J Gastroenterol 2005, 100, 1072–1081, doi: 10.1111/j.1572-0241.2005.41334.x.Open DOISearch in Google Scholar
HAMAGUCHI; KOJIMA; TAKEDA; NAKAGAWA; TANIGUCHI; FUJII; et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005, 143, 722–728, doi: 10.7326/0003-4819-143-10-200511150-00009.Open DOISearch in Google Scholar
BHATIA; CURZEN; CALDER; BYRNE. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? Eur Heart J 2012, 33, 1190–1200, doi: 10.1093/eurheartj/ehr453.Open DOISearch in Google Scholar
PROMRAT; KLEINER; NIEMEIER; JACKVONY; KEARNS; WANDS; et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 2010, 51, 121–129, doi: 10.1002/hep.23276.Open DOISearch in Google Scholar
BRIL; BARB; PORTILLO-SANCHEZ; BIERNACKI; LOMONACO; SUMAN; et al. Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease. Hepatology 2017, 65, 1132–1144, doi: 10.1002/hep.28985.Open DOISearch in Google Scholar
SEO. Letter: Hepatic Fibrosis and Steatosis in Metabolic Syndrome (J Obes Metab Syndr 2022;31:61–9). J Obes Metab Syndr 2022, 31, 350–351, doi: 10.7570/jomes22049.Open DOISearch in Google Scholar
